Center for State, Tribal, Local, and Territorial Support (CSTLTS), CDC/ATSDR Tribal Advisory Committee (TAC) Meeting, 505-506 [2019-28450]

Download as PDF lotter on DSKBCFDHB2PROD with NOTICES Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices 533–6800; Toll Free: 1 (800) CDC–INFO; Email: ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on February 12, 2018, and will terminate on February 12, 2020. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Considered: The agenda will include discussions on: Work Group and Subcommittee Reports; Update on the Status of SEC Petitions; Plans for the April 2020 Advisory Board Meeting; and Advisory Board Correspondence. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal VerDate Sep<11>2014 17:53 Jan 03, 2020 Jkt 250001 Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–28451 Filed 1–3–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Center for State, Tribal, Local, and Territorial Support (CSTLTS), CDC/ ATSDR Tribal Advisory Committee (TAC) Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The Centers for Disease Control and Prevention (CDC)/Agency for Toxic Substances and Disease Registry (ATSDR), announces the Winter 2020 CDC/ATSDR Tribal Advisory Committee (TAC) meeting. The meeting is being hosted by CDC/ ATSDR, in-person only, and is open to the public, except for certain hours set aside for tribal caucus. Attendees must pre-register for the event by Friday, February 21, 2020, at the following link: https://www.cdc.gov/tribal/ meetings.html. SUMMARY: The meeting will be held March 12, 2020, 9:30 a.m. to 5:30 p.m., EDT; and March 13, 2020, 9:30 a.m. to 5:30 p.m., EDT. ADDRESSES: CDC, Chamblee Campus, Building 106, Rooms 1A/1B, 4770 Buford Highway, Atlanta, GA 30341– 3717. DATES: FOR FURTHER INFORMATION CONTACT: CAPT Carmen Clelland, PharmD, MPA, MPH, Director, Office of Tribal Affairs and Strategic Alliances, Center for State, Tribal, Local, and Territorial Support, CDC, 4770 Buford Highway, Mailstop V18–4, Atlanta, GA 30341–3717; Telephone: (404) 498–2205; Email: cclelland@cdc.gov. SUPPLEMENTARY INFORMATION: This meeting is being held in accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 505 Consultation and Coordination with Indian Tribal Governments. Purpose: The purpose of the TAC meeting is to advance CDC/ATSDR support for and collaboration with American Indian and Alaska Native (AI/ AN) tribal nations and to improve the health of AI/AN people by pursuing goals that include assisting in eliminating the health disparities faced by tribal nations; ensuring that access to critical health and human services and public health services is maximized to advance or enhance the social, physical, and economic status of AI/AN people; and promoting health equity for all AI/ AN people and communities. To advance these goals, CDC/ATSDR conducts government-to-government meetings with elected tribal officials or their authorized representatives. These meetings offer open and free exchange of information and opinion among parties that leads to mutual understanding. Information about the TAC, CDC/ ATSDR’s Tribal Consultation Policy, and previous meetings is available at https://www.cdc.gov/tribal/ consultation-support/tribalconsultation/sessions.html. Matters To Be Considered: The agenda will include discussions on tribal priorities for CDC and ATSDR, public health capacity in Indian Country, and programmatic highlights. AI/AN tribal nations also will have an opportunity to present testimony about tribal health issues. All tribal leaders are encouraged to submit written testimony by 5:00 p.m. (EST) Friday, February 21, 2020, to Captain Carmen Clelland, Director, Office of Tribal Affairs and Strategic Alliances, via mail at 4770 Buford Highway, Mailstop V18–4, Atlanta, GA 30341–3717, or by email to TribalSupport@cdc.gov. Guidance for developing tribal testimony for CDC/ ATSDR is available at www.cdc.gov/ tribal/consultation-support/tac/ index.html. Based on the number of tribal leaders giving testimony and the time available, it may be necessary to limit the time for each presenter. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\06JAN1.SGM 06JAN1 506 Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–28450 Filed 1–3–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates up to 120 people. The public is also welcome to listen to the meeting via teleconference at 1–800– 857–2850, passcode: 2622054; 100 teleconference lines are available. DATES: The meeting will be held on March 5, 2020, 9:00 a.m. to 5:00 p.m., EST, and March 6, 2020, 9:00 a.m. to 12:00 p.m., EST. ADDRESSES: Centers for Disease Control and Prevention, Global Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE, Atlanta, Georgia 30329–4027 and teleconference at 1– 800–857–2850, passcode: 2622054. FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton Road NE, Mailstop H16–3, Atlanta, Georgia 30329–4027; Telephone: (404) 498–0730; Email: hicpac@cdc.gov. SUPPLEMENTARY INFORMATION: Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt of written public comment is February 20, 2020. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one singlespaced typed page in length and lotter on DSKBCFDHB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:53 Jan 03, 2020 Jkt 250001 delivered in 3 minutes or less. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Written comments received in advance of the meeting will be included in the official record of the meeting. Registration is required to attend in person or on the phone. Interested parties must be processed in accordance with established federal policies and procedures and may register at https://www.cdc.gov/hicpac. Purpose: The Committee is charged with providing advice and guidance to the Director, Division of Healthcare Quality Promotion (DHQP), the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, Health and Human Services, regarding (1) the practice of healthcare infection prevention and control; (2) strategies for surveillance, prevention, and control of infections, antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of CDC guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Considered: The agenda will include updates on CDC’s activities for prevention of healthcare-associated infections. It will also include updates from the following HICPAC workgroups: The Healthcare Personnel Guideline Workgroup; the Neonatal Intensive Care Unit (NICU) Guideline Workgroup; the National Healthcare Safety Network (NHSN) Workgroup; and the Bloodstream Infection Workgroup. The agenda also includes updates on CDC and DHQP activities. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–28449 Filed 1–3–20; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10237] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments on the collection(s) of information must be received by the OMB desk officer by February 5, 2020. ADDRESSES: When commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be received by the OMB desk officer via one of the following transmissions: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–5806 OR Email: OIRA_submission@omb.eop.gov. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/ PRA=Listing.html. DATES: E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 85, Number 3 (Monday, January 6, 2020)]
[Notices]
[Pages 505-506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28450]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Center for State, Tribal, Local, and Territorial Support 
(CSTLTS), CDC/ATSDR Tribal Advisory Committee (TAC) Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC)/Agency 
for Toxic Substances and Disease Registry (ATSDR), announces the Winter 
2020 CDC/ATSDR Tribal Advisory Committee (TAC) meeting. The meeting is 
being hosted by CDC/ATSDR, in-person only, and is open to the public, 
except for certain hours set aside for tribal caucus. Attendees must 
pre-register for the event by Friday, February 21, 2020, at the 
following link: https://www.cdc.gov/tribal/meetings.html.

DATES: The meeting will be held March 12, 2020, 9:30 a.m. to 5:30 p.m., 
EDT; and March 13, 2020, 9:30 a.m. to 5:30 p.m., EDT.

ADDRESSES: CDC, Chamblee Campus, Building 106, Rooms 1A/1B, 4770 Buford 
Highway, Atlanta, GA 30341-3717.

FOR FURTHER INFORMATION CONTACT: CAPT Carmen Clelland, PharmD, MPA, 
MPH, Director, Office of Tribal Affairs and Strategic Alliances, Center 
for State, Tribal, Local, and Territorial Support, CDC, 4770 Buford 
Highway, Mailstop V18-4, Atlanta, GA 30341-3717; Telephone: (404) 498-
2205; Email: [email protected].

SUPPLEMENTARY INFORMATION: This meeting is being held in accordance 
with Presidential Executive Order No. 13175, November 6, 2000, and the 
Presidential Memorandum of November 5, 2009, and September 23, 2004, 
Consultation and Coordination with Indian Tribal Governments.
    Purpose: The purpose of the TAC meeting is to advance CDC/ATSDR 
support for and collaboration with American Indian and Alaska Native 
(AI/AN) tribal nations and to improve the health of AI/AN people by 
pursuing goals that include assisting in eliminating the health 
disparities faced by tribal nations; ensuring that access to critical 
health and human services and public health services is maximized to 
advance or enhance the social, physical, and economic status of AI/AN 
people; and promoting health equity for all AI/AN people and 
communities. To advance these goals, CDC/ATSDR conducts government-to-
government meetings with elected tribal officials or their authorized 
representatives. These meetings offer open and free exchange of 
information and opinion among parties that leads to mutual 
understanding.
    Information about the TAC, CDC/ATSDR's Tribal Consultation Policy, 
and previous meetings is available at https://www.cdc.gov/tribal/consultation-support/tribal-consultation/sessions.html.
    Matters To Be Considered: The agenda will include discussions on 
tribal priorities for CDC and ATSDR, public health capacity in Indian 
Country, and programmatic highlights. AI/AN tribal nations also will 
have an opportunity to present testimony about tribal health issues. 
All tribal leaders are encouraged to submit written testimony by 5:00 
p.m. (EST) Friday, February 21, 2020, to Captain Carmen Clelland, 
Director, Office of Tribal Affairs and Strategic Alliances, via mail at 
4770 Buford Highway, Mailstop V18-4, Atlanta, GA 30341-3717, or by 
email to [email protected]. Guidance for developing tribal 
testimony for CDC/ATSDR is available at www.cdc.gov/tribal/consultation-support/tac/. Based on the number of tribal 
leaders giving testimony and the time available, it may be necessary to 
limit the time for each presenter. Agenda items are subject to change 
as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 506]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-28450 Filed 1-3-20; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.